Trials / Completed
CompletedNCT01543880
Safety and Efficacy of Long-term Somatropin Treatment in Adults
Non-interventional Study of Safety and Efficacy of Long-term Somatropin Treatment in Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 752 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (Norditropin®).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | Prescribed at the discretion of the treating physician according to product labelling |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2013-12-01
- Completion
- 2014-06-01
- First posted
- 2012-03-05
- Last updated
- 2015-04-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01543880. Inclusion in this directory is not an endorsement.